175 related articles for article (PubMed ID: 2903159)
1. A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.
Cheifetz S; Ling N; Guillemin R; Massagué J
J Biol Chem; 1988 Nov; 263(33):17225-8. PubMed ID: 2903159
[TBL] [Abstract][Full Text] [Related]
2. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.
Moustakas A; Takumi T; Lin HY; Lodish HF
J Biol Chem; 1995 Jan; 270(2):765-9. PubMed ID: 7822308
[TBL] [Abstract][Full Text] [Related]
3. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
Chapman SC; Bernard DJ; Jelen J; Woodruff TK
Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827
[TBL] [Abstract][Full Text] [Related]
4. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line.
Ying C; Zhang Z; Huang G; Li SQ; Ying SY
J Endocrinol Invest; 1996 Jan; 19(1):6-11. PubMed ID: 8851685
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inhibin signal transduction.
Bernard DJ; Chapman SC; Woodruff TK
Recent Prog Horm Res; 2001; 56():417-50. PubMed ID: 11237224
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of binding of human seminal alpha-inhibin-92 to human pituitary membranes.
Ramasharma K; Li CH
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3595-8. PubMed ID: 3035540
[TBL] [Abstract][Full Text] [Related]
9. A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-beta.
Yamashita H; Okadome T; Franzén P; ten Dijke P; Heldin CH; Miyazono K
J Biol Chem; 1995 Jan; 270(2):770-4. PubMed ID: 7822309
[TBL] [Abstract][Full Text] [Related]
10. Identification of the two types of specific receptor for activin/EDF expressed on Friend leukemia and embryonal carcinoma cells.
Kondo S; Hashimoto M; Etoh Y; Murata M; Shibai H; Muramatsu M
Biochem Biophys Res Commun; 1989 Jun; 161(3):1267-72. PubMed ID: 2545199
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
[TBL] [Abstract][Full Text] [Related]
12. Inhibin binding sites and proteins in pituitary, gonadal, adrenal and bone cells.
Farnworth PG; Harrison CA; Leembruggen P; Chan KL; Stanton PG; Ooi GT; Rahman NA; Huhtaniemi IT; Findlay JK; Robertson DM
Mol Cell Endocrinol; 2001 Jun; 180(1-2):63-71. PubMed ID: 11451573
[TBL] [Abstract][Full Text] [Related]
13. Heterodimeric transforming growth factor beta. Biological properties and interaction with three types of cell surface receptors.
Cheifetz S; Bassols A; Stanley K; Ohta M; Greenberger J; Massagué J
J Biol Chem; 1988 Aug; 263(22):10783-9. PubMed ID: 2899081
[TBL] [Abstract][Full Text] [Related]
14. Is the action of inhibin mediated via a unique receptor?
Robertson DM; Hertan R; Farnworth PG
Rev Reprod; 2000 Sep; 5(3):131-5. PubMed ID: 11006162
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatic transforming growth factor receptors during late gestation in the fetal rat.
Gruppuso PA
Endocrinology; 1989 Dec; 125(6):3037-43. PubMed ID: 2555136
[TBL] [Abstract][Full Text] [Related]
17. Identification of an inhibin receptor in gonadal tumors from inhibin alpha-subunit knockout mice.
Draper LB; Matzuk MM; Roberts VJ; Cox E; Weiss J; Mather JP; Woodruff TK
J Biol Chem; 1998 Jan; 273(1):398-403. PubMed ID: 9417095
[TBL] [Abstract][Full Text] [Related]
18. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
[TBL] [Abstract][Full Text] [Related]
19. Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.
Centrella M; McCarthy TL; Canalis E
Mol Cell Biol; 1991 Jan; 11(1):250-8. PubMed ID: 1846021
[TBL] [Abstract][Full Text] [Related]
20. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
Lebrun JJ; Vale WW
Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
